Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Analgesic effect of levobupivacaine alone vs levobupivacaine + sufentanil + epinephrine in continuous paravertebral block after VATS
2015-002169-50Phase 4Completed
- Sponsor
- Karolinska Institutet
- Start
- Sep 2015
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of levobupivacaine, sufentanil and epinephrine in postoperative pain (2 arms), sponsored by Karolinska Institutet. Primary endpoint: Cumulated intravenous PCA morphine consumption at 72 hours. Started Sep 2015; status: completed.
02
Drugs
levobupivacainesufentanilepinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on 2015-002169-50.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002169-50.